MediWound Ltd (M8W) - Total Liabilities

Latest as of December 2025: €42.62 Million EUR ≈ $49.83 Million USD

Based on the latest financial reports, MediWound Ltd (M8W) has total liabilities worth €42.62 Million EUR (≈ $49.83 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is MediWound Ltd growing its equity to track the company's year-over-year net asset growth rate.

MediWound Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how MediWound Ltd's total liabilities have evolved over time, based on quarterly financial data. See MediWound Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

MediWound Ltd Competitors by Total Liabilities

The table below lists competitors of MediWound Ltd ranked by their total liabilities.

Company Country Total Liabilities
Sajo Ind
KO:007160
Korea ₩617.05 Billion
Bossa Ticaret ve Sanayi Isletmeleri TAS
IS:BOSSA
Turkey TL4.18 Billion
DCW Limited
NSE:DCW
India Rs10.15 Billion
Servet Gayrimenkul Yatirim Ortakligi AS
IS:SRVGY
Turkey TL10.36 Billion
Bergbahnen Engelberg Truebsee Titlis Bet AG
SW:TIBN
Switzerland CHF102.51 Million
Nam Viet Corp
VN:ANV
Vietnam ₫2.30 Trillion
Carasent ASA
ST:CARA
Sweden Skr141.85 Million
Taisol Electronics Co Ltd
TW:3338
Taiwan NT$1.66 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down MediWound Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MediWound Ltd (M8W) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.33 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.98 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.49 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how MediWound Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for MediWound Ltd (2016–2025)

The table below shows the annual total liabilities of MediWound Ltd from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 €42.62 Million
≈ $49.83 Million
+0.66%
2024-12-31 €42.34 Million
≈ $49.50 Million
+21.45%
2023-12-31 €34.86 Million
≈ $40.76 Million
-10.84%
2022-12-31 €39.10 Million
≈ $45.71 Million
+60.74%
2021-12-31 €24.33 Million
≈ $28.44 Million
+2.22%
2020-12-31 €23.80 Million
≈ $27.82 Million
-6.38%
2019-12-31 €25.42 Million
≈ $29.72 Million
-3.36%
2018-12-31 €26.30 Million
≈ $30.75 Million
-23.79%
2017-12-31 €34.52 Million
≈ $40.35 Million
+23.29%
2016-12-31 €27.99 Million
≈ $32.73 Million
--

About MediWound Ltd

F:M8W Germany Biotechnology
Market Cap
$181.81 Million
€155.51 Million EUR
Market Cap Rank
#17026 Global
#1610 in Germany
Share Price
€12.10
Change (1 day)
+0.83%
52-Week Range
€11.60 - €17.00
All Time High
€19.60
About

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn cen… Read more